Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
9 participants
OBSERVATIONAL
2019-07-08
2020-02-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multi-Component Breath Alcohol Intervention
NCT06124898
Multi-Component Breath Alcohol Intervention Phase 3
NCT06994962
Remote Monitoring and Contingency Management Reinforcement for Alcohol Abstinence
NCT01307345
Smartphone Technology: Young Adult Drinking
NCT02963818
Breathalyzer Validation Study
NCT04086576
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific objective of this study is to determine whether the printed electrochemical gas sensor designed to measure blood alcohol level will be sensitive and reliable when compared to a standard measure of blood alcohol level taken by a breathalyzer. If this sensor proves sensitive to changes in blood alcohol level and can reliably measure blood alcohol level relative to a "gold standard" method, there are significant opportunities to use this technology in consumer health applications and clinical research.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartwatch to measure Blood Alcohol Level (BAL)
Subjects will wear a wristwatch with a sensor that measures blood alcohol level during a 1-hour period of consuming alcohol followed by a 5 hour observation period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Can provide proof of age with state or federal picture Identification.
3. Consumes an average of ≥7 standard drinks per week (women) or ≥14 drinks per week (men) over the 28 days prior to consent.
4. Has consumed at least 4 standard drinks on a single day on at least two days in the past 28 days prior to consent.
5. Has a blood alcohol level = 0.000 at time of consent.
6. Is able to understand and provide written informed consent.
7. Body weight ≥ 120 lbs and ≤ 250 pounds
8. Subjects can speak and understand English
Exclusion Criteria
2. Clinical Institute Withdrawal Assessment at ≥10.
3. Meets DSM-5 diagnosis of current major depression, bipolar disorder, schizophrenia, bulimia/anorexia, dementia, or a substance use disorder other than alcohol, nicotine, marijuana, or caffeine
4. If female, pregnant or nursing.
5. If female, does not agree to use an accepted form of birth control
6. Has medical or mental condition for which further alcohol exposure at the planned dose range would be contraindicated.
7. Taking medication for which drinking would be contraindicated.
8. Clinically significant abnormal ECG.
9. AST or ALT ≥ 3x the upper limit of normal.
10. Current risk of suicidality.
11. Has taken medications that are used to treat AUD in the past 90 days.
12. Has received alcohol counseling or other non-pharmacologic intervention to treat alcohol use disorder in the past 90 days.
13. Has urine toxicology results positive for cocaine, opioids, amphetamines, buprenorphine, methadone, or methamphetamines.
14. Smokes greater than 5 cigarettes per day.
15. Unable to comfortably abstain from nicotine for a period of 8 hours.
16. Wearing cologne, perfume, aftershave or any other scented oil or alcohol-based beauty product on the day of the Alcohol Lab Visit.
17. Has dietary restrictions that would preclude participating.
21 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KWJ Engineering
INDUSTRY
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Boston Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Devine
Assistant Professor, Dept of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Devine, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston University Psychiatry Research Center, Clinical Studies Unit
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-36914
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.